The National Institutes of Health (NIH) announced that it will invest $10.1 million in supplemental funding to support the research of more than 80 grantees to investigate the effects of sex in pre-clinical and clinical studies. SWHR applauds the NIH for taking such an important step in encouraging researchers to study biological differences in a wide range of disease areas.
Although $10.1 million seems like a substantial investment, once these monies are distributed among the researchers, this amount actually results in a limited increase when compared to the ever-rising cost of doing research in the U.S. SWHR believes that analysis of biological sex differences should become the norm in medical research that is examining diseases and conditions that impact both men and women. We will continue to advocate for appropriate funding for the NIH to facilitate this type of research and look forward to working with the Agency to ensure that all researchers increasingly understand the importance of biological sex.